Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors

Current Opinion in Immunology

Volumn 17, Issue 3, 2005, Pages 312-319

  Mingari, Maria Cristina ^a,b   Pietra, Gabriella ^c   Moretta, Lorenzo ^b,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA ANTIGEN CLASS 1 SPECIFIC INHIBITORY RECEPTOR; INHIBITORY NATURAL KILLER CELL RECEPTOR; KILLER IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE RECEPTOR; MEMBRANE PROTEIN; PROTEIN LIR; RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

CELL DEATH; CELL FUNCTION; CELL SURFACE; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MULTIGENE FAMILY; NATURAL KILLER CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 18844363253     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.03.006     Document Type: Review

References (70)

1. A. Moretta, G. Tambussi, C. Bottino, G. Tripodi, A. Merli, E. Ciccone, G. Pantaleo, and L. Moretta A novel surface antigen expressed by a subset of human CD3-CD16+ Natural Killer cells. role in the activation and regulation of cytolytic function J Exp Med 171 1990 695 714
2. A. Moretta, C. Bottino, D. Pende, G. Tripodi, G. Tambussi, O. Viale, A. Orengo, M. Barbaresi, A. Merli, E. Ciccone, and L. Moretta Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition J Exp Med 172 1990 1589 1598
3. A. Moretta, M. Vitale, C. Bottino, A.M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta p58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities J Exp Med 178 1993 597 604
4. A. Moretta, C. Bottino, M. Vitale, D. Pende, R. Biassoni, M.C. Mingari, and L. Moretta Receptors for HLA class-I molecules in human natural killer cells Annu Rev Immunol 14 1996 619 648
5. F.M. Karlhofer, R.K. Ribaudo, and W.M. Yokoyama MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells Nature 358 1992 66 70
6. W.M. Yokoyama, and W.E. Seaman The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex Annu Rev Immunol 11 1993 613 635
7. A. Moretta, C. Bottino, M. Vitale, D. Pende, C. Cantoni, M.C. Mingari, R. Biassoni, and L. Moretta Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis Annu Rev Immunol 19 2001 197 223
8. + CTLs.
9. L. Moretta, and A. Moretta Killer immunoglobulin-like receptors Curr Opin Immunol 16 2004 626 633
10. E. Vivier, and M. Daëron Immunoreceptor tyrosine-based inhibition motifs (ITIMs) Immunol Today 18 1997 286 291
11. E.O. Long Regulation of immune responses through inhibitory receptors Annu Rev Immunol 17 1999 875 904
12. S. Ferrini, A. Cambiaggi, R. Meazza, S. Sforzini, S. Marciano, M.C. Mingari, and L. Moretta T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function Eur J Immunol 24 1994 2294 2298
13. M.C. Mingari, C. Vitale, A. Cambiaggi, F. Schiavetti, G. Melioli, S. Ferrini, and A. Poggi Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production Int Immunol 7 1995 697 703
14. J.H. Phillips, J.E. Gumperz, P. Parham, and L.L. Lanier Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes Science 268 1995 403 405
15. M.C. Mingari, M. Ponte, C. Cantoni, C. Vitale, F. Schiavetti, S. Bertone, R. Bellomo, A.T. Cappai, and R. Biassoni HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells Int Immunol 9 1997 485 491
16. + T cells are present in healthy donors. They report their frequency, surface phenotype, cytokine production, and antigen specificity.
17. E. Vivier, and N. Anfossi Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future Nat Rev Immunol 4 2004 190 198 An updated review on T cells expressing inhibitory NK receptors in mice and humans.
18. L. Battistini, G. Borsellino, G. Sawicki, F. Poccia, M. Salvetti, G. Ristori, and C.F. Brosnan Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors J Immunol 159 1997 3723 3730
19. C. Vilches, and P. Parham KIR: diverse, rapidly evolving receptors of innate and adaptive immunity Annu Rev Immunol 20 2002 217 251
20. M. Vitale, S. Sivori, D. Pende, R. Augugliaro, C. Di Donato, A. Amoroso, M. Malnati, C. Bottino, L. Moretta, and S. Moretta Physical and functional independency of p70 and p58 Nk cell receptors for HLA-class I. Their role in definition of different group of alloreactive NK cell clones Proc Natl Acad Sci USA 93 1996 1453 1457
21. V. Litwin, J. Gumperz, P. Parham, J.H. Phillips, and L.L. Lanier NKB1:a natural killer cell receptor involved in the recognition of polymorphic HLA-B moelcules J Exp Med 180 1994 537 544
22. D. Pende, R. Biassoni, C. Cantoni, S. Verdiani, M. Falco, C. Di Donato, L. Accame, C. Bottino, A. Moretta, and L. Moretta The natural Killer cell receptor specific for HLA-A allotypes. A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140kD disulphide-linked dimer J Exp Med 184 1996 505 518
23. M. Colonna, F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells J Exp Med 186 1997 1809 1818
24. D. Cosman, N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M.L. Hsu A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules Immunity 7 1997 273 282
25. B.E. Willcox, L.M. Thomas, and P.J. Bjorkman Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor Nat Immunol 4 2003 913 919
26. V.M. Braud, D.S. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, and J.H. Phillips HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C Nature 391 1998 795 799
27. P. Tomasec, V.M. Braud, C. Rickards, M.B. Powell, B.P. McSharry, S. Gadola, V. Cerundolo, L.K. Borysiewicz, A.J. McMichael, and G.W. Wilkinson Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40 Science 287 2000 1031 1033
28. M.C. Mingari, F. Schiavetti, M. Ponte, C. Vitale, E. Maggi, S. Romagnani, J. Demarest, G. Pantaleo, A.S. Fauci, and L. Moretta Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations Proc Natl Acad Sci USA 93 1996 12433 12438
29. M.C. Mingari, M. Ponte, C. Cantoni, C. Vitale, F. Schiavetti, S. Bertone, R. Bellomo, A.T. Cappai, and R. Biassoni HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells Int Immunol 9 1997 485 491
30. N. Anfossi, V. Pascal, E. Vivier, and S. Ugolini Biology of T memory type 1 cells Immunol Rev 181 2001 269 278
31. F. Vely, M. Peyrat, C. Couedel, J. Morcet, F. Halary, F. Davodeau, F. Romagne, E. Scotet, X. Saulquin, and E. Houssaint Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements J Immunol 166 2001 2487 2494
32. M. Uhrberg, N.M. Valiante, N.T. Young, L.L. Lanier, J.H. Phillips, and P. Parham The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical TCR rearrangement express highly diverse killer cell Ig-like receptor patterns J Immunol 166 2001 3923 3932
33. D.E. Speiser, D. Valmori, D. Rimoldi, M.J. Pittet, D. Lienard, V. Cerundolo, H.R. MacDonald, J.C. Cerottini, and P. Romero CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients Eur J Immunol 29 1999 1990 1999
34. M.J. Pittet, D.E. Speiser, D. Valmori, J.C. Cerottini, and P. Romero Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression J Immunol 164 2000 1148 1152
35. + T cells isolated ex vivo.
36. N.T. Young, M. Uhrberg, J.H. Phillips, L.L. Lanier, and P. Parham Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL J Immunol 166 2001 3933 3941
37. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
38. V. Appay, P.R. Dunbar, M. Callan, P. Klenerman, G.M. Gillespie, L. Papagno, G.S. Ogg, A. King, F. Lechner, and C.A. Spina Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections Nat Med 8 2002 379 385
39. N. Rufer, A. Zippelius, P. Batard, M.J. Pittet, I. Kurth, P. Corthesy, J.C. Cerottini, S. Leyvraz, E. Roosnek, M. Nabholz, and P. Romero Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions Blood 102 2003 1779 1787
40. EM, their differentiation stages, and the models for their generation and maintenance in humans and mice.
41. S. Santourlidis, H.I. Trompeter, S. Weinhold, B. Eisermann, K.L. Meyer, P. Wernet, and M. Uhrberg Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells J Immunol 169 2002 4253 4261
42. H.W. Chan, Z.B. Kurago, C.A. Stewart, M.J. Wilson, M.P. Martin, B.E. Mace, M. Carrington, J. Trowsdale, and C.T. Lutz DNA methylation maintains allele-specific KIR gene expression in human natural killer cells J Exp Med 197 2003 245 255 This interesting study, together with previous one (reference [41]) illustrates the role of DNA methylation in determining KIR gene expression. The authors also provide evidence that this mechanism is responsible for maintaining the monoallelic expression of KIR.
43. B. Huard, and L. Karlsson KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement Nature 403 2000 325 328
44. + precursors in the presence of IL-21 results in accelerated cell maturation towards NK cells. It also provides the first evidence that KIRs can be expressed 'de novo' in vitro.
45. M.C. Mingari, M. Ponte, S. Bertone, F. Schiavetti, C. Vitale, R. Bellomo, A. Moretta, and L. Moretta HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin-15 induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells Proc Natl Acad Sci USA 95 1998 1172 1177
46. S. Bertone, F. Schiavetti, R. Bellomo, C. Vitale, M. Ponte, L. Moretta, and M.C. Mingari Transforming growth factor-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes Eur J Immunol 29 1999 23 29
47. L. Derre, M. Corvaisier, M.C. Pandolfino, E. Diez, F. Jotereau, and N. Gervois Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy J Immunol 168 2002 4864 4870
48. B. Jabri, J.M. Selby, H. Negulescu, L. Lee, A.I. Roberts, A. Beavis, M. Lopez-Botet, E.C. Ebert, and R.J. Winchester TCR specificity dictates CD94/NKG2A expression by human CTL Immunity 17 2002 487 499
49. A. D'Andrea, C. Chang, J.H. Phillips, and L.L. Lanier Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles J Exp Med 184 1996 789 794
50. A. De Maria, A. Ferraris, M. Guastella, S. Pilia, C. Cantoni, L. Polero, M.C. Mingari, D. Bassetti, A.S. Fauci, and L. Moretta Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions Proc Natl Acad Sci USA 94 1997 10285 10288
51. H. Ikeda, B. Lethe, F. Lehmann, N. van Baren, J.F. Baurain, C. de Smet, H. Chambost, M. Vitale, A. Moretta, T. Boon, and P.G. Coulie Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor Immunity 6 1997 199 208
52. A.B. Bakker, J.H. Phillips, C.G. Figdor, and L.L. Lanier Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, T cells, and antigen-specific CTL J Immunol 160 1998 5239 5245 (1998)
53. N. Guerra, M. Guillard, E. Angevin, H. Echchakir, B. Escudier, A. Moretta, S. Chouaib, and A. Caignard Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas Blood 95 2000 2883 2889
54. N. Guerra, F. Michel, A. Gati, C. Gaudin, Z. Mishal, B. Escudier, O. Acuto, S. Chouaib, and A. Caignard Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction Blood 100 2002 2874 2881
55. L. Berg, G.C. Riise, D. Cosman, T. Bergstrom, S. Olofsson, K. Karre, and E. Carbone LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients Lancet 361 2003 1099 1101
56. N. Ince, B. Harnisch, Z. Xu, C. Lange, L. Moretta, M. Lederman, and J. Lieberman Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen specific effector CD8 T cells and its impact on CD8 T cell function Immunology 112 2004 531 542 This study shows that LIR1 engagement can inhibit IFN-γ production but not cytolytic activity of virus-specific CTLs.
57. G. Pietra, C. Romagnani, M. Falco, M. Vitale, R. Castriconi, D. Pende, E. Millo, S. Anfossi, R. Biassoni, L. Moretta, and M.C. Mingari The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR α/β-mediated recognition Eur J Immunol 31 2001 3687 3693
58. C. Romagnani, G. Pietra, M. Falco, E. Millo, P. Mazzarino, R. Biassoni, A. Moretta, L. Moretta, and M.C. Mingari Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells Proc Natl Acad Sci USA 99 2002 11328 11333
59. L. Moretta, C. Romagnani, G. Pietra, A. Moretta, and M.C. Mingari NK-CTLs, a novel HLA-E-restricted T-cell subset Trends Immunol 24 2003 136 143 A review describing the recently identified, HLA-specific CTL subset. Their anti-viral and anti-tumour activity are described as well as their possible negative effect in transplant rejection.
60. + T cell subset, suggesting that they may play a role in defences against CMV and, possibly, other pathogens.
61. D.E. Speiser, M.J. Pittet, D. Valmori, R. Dunbar, D. Rimoldi, D. Lienard, H.R. MacDonald, J.C. Cerottini, V. Cerundolo, and P. Romero In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes J Exp Med 190 1999 775 782
62. G. Perrin, D. Speiser, A. Porret, A.L. Quiquerez, P.R. Walker, and P.Y. Dietrich Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma Immunol Lett 81 2002 125 132
63. K.J. Malmberg, V. Levitsky, H. Norell, C.T. de Matos, M. Carlsten, K. Schedvins, H. Rabbani, A. Moretta, K. Soderstrom, J. Levitskaya, and R. Kiessling IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism J Clin Invest 110 2002 1515 1523
64. F. Halary, M.A. Peyrat, E. Champagne, M. Lopez-Botet, A. Moretta, L. Moretta, H. Vie, J.J. Fournie, and M. Bonneville Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors Eur J Immunol 27 1997 2812 2821
65. B. Huard, and L. Karlsson A subpopulation of CD8+ T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: evidence for a role of KIR in the control of peripheral tolerance Eur J Immunol 30 2000 1665 1675
66. S. Ugolini, C. Arpin, N. Anfossi, T. Walzer, A. Cambiaggi, R. Forster, M. Lipp, R.E. Toes, C.J. Melief, J. Marvel, and E. Vivier Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells Nat Immunol 2 2001 430 435
67. F. Marti, C.W. Xu, A. Selvakumar, R. Brent, B. Dupont, and P.D. King LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase Proc Natl Acad Sci USA 95 1998 11810 11815
68. A. Gati, N. Guerra, C. Gaudin, S. Da Rocha, B. Escudier, Y. Lecluse, A. Bettaieb, S. Chouaib, and A. Caignard CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling Cancer Res 63 2003 7475 7482
69. Y.J. Chwae, M.J. Chang, S.M. Park, H. Yoon, H.J. Park, S.J. Kim, and J. Kim Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells J Immunol 169 2002 3726 3735
70. G. Pietra, C. Romagnani, P. Mazzarino, E. Millo, L. Moretta, and M.C. Mingari Comparative analysis of the NK or NK-CTL-mediated lysis of immature or mature autologous dendritic cells Eur J Immunol 33 2003 3427 3432 Different from NK cells, NK-CTLs do not kill autologous DCs presenting HLA-E-bound self peptides. However, when DCs carry HLA-E-bound foreign peptides, immature DCs are efficiently killed. This might occur in CMV infection and may result in a NK-CTL mediated control of DC survival and function. Indeed, only those DCs expressing adequate amounts of HLA-class I (i.e. mature DCs) will be resistant to NK-CTL-mediated lysis thanks to the engagement of iNKRs.